FFecundis
Fecundis is a Barcelona-based reproductive medtech/biotech company developing sperm-focused technologies for assisted reproduction. Its lead product, HyperSperm, is a sequential-step kit that recreates in vitro the physiological transitions of sperm capacitation to improve IVF and ICSI outcomes, and the company is in the regulatory phase ahead of a planned market launch. Founded on sperm-biology research from Argentina (with offices in Buenos Aires and Rosario) and headquartered at the Barcelona Science Park, it closed a $2.4M seed round in October 2024 led by DuneGlass Capital.
SectorsBiotech, Medtech, Fertility & Reproductive Health, Life Sciences
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
D
Dario Krapf
Co-founder & Chief Scientific Officer
M
Mariano Buffone
Co-founder & Chief Scientific Officer
R
Rita Vassena
Co-founder
Global models 5
OOverture Life
United States · overture.life ↗
Overture Life develops lab devices and kits that automate and standardise IVF steps, including sperm preparation, and sells them to fertility clinics to improve IVF and ICSI outcomes.
$55M+Comparable
CConceivable Life Sciences
United States · conceivable.life ↗
Conceivable builds IVF lab technology, including sperm handling and ICSI automation, that it sells to clinics to raise fertilisation and pregnancy rates.
$50M+Comparable
IInherent Biosciences
United States · inherentbio.com ↗
Inherent Biosciences builds on sperm biology (sperm epigenetics) to create products for male-factor infertility that feed into clinic decisions on assisted reproduction.
$10M+Comparable
N
Nanovare
France · nanovare.com ↗
Nanovare is a sperm-focused reproductive medtech that sells sperm-analysis technology to fertility clinics and labs to improve male-factor diagnosis and IVF work.
$6M+Comparable
Z
ZyMot Fertility
United States · www.zymot.com ↗
ZyMot sells a single-use microfluidic device that selects high-quality sperm for IVF and ICSI, the same product type as HyperSperm (a disposable sperm-preparation product sold to clinics); it was later acquired by CooperSurgical.
UndisclosedComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
AAortyx
Barcelona
Series A · €16.9M
NNuubo
Madrid
Series B (estimated) · €16.3M
Notes: Most funded first
Investors 8
Open as list →
CCapital Cell
capitalcell.com
MMedex Partners
medexpartners.com
DDuneGlass Capital
G
GRIDX
Z
Zentynel Frontier Investments
G
Grid Exponential
GGUX Global Investments
V
Venturance Alternative Assets
Funding rounds 2
News 4
Open as list →| Published | Article |
|---|---|
| 2026-06-30 |
Fecundis HyperSperm technology increases the number and quality of embryos produced through in vitro fertilisation ↗
Parc Científic de Barcelona
2026-06-30 |
| 2025-05-14 |
The innovative HyperSperm technology from Fecundis improves the efficiency of in vitro fertilization and opens new doors in reproductive medicine ↗
Parc Científic de Barcelona
2025-05-14 |
| 2024-10-08 |
Fecundis secures $2.4 million in a seed funding round ↗
Parc Científic de Barcelona
2024-10-08 |
| 2023-12-11 |
#48 El caso Fecundis — Rita Vassena ↗
BioEmprendedores
2023-12-11 |